NexusTrade Loading NexusTrade… Taking too long? Reload this page

About GeneDx Holdings Corp. Class A Common Stock (WGS)

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Ticker
WGS
Exchange
XNAS
Sector
Healthcare
Industry
Diagnostics & Research

Company profile updated October 10, 2026.

Stored market snapshot

As of October 8, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$67.73
Company market capitalization (USD)
$2,019,880,701.93
Price / book
8.27×

Research WGS

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: